3 Appendix 1, Regulation (EU) 2019/1390

In forcesince 31 Jul 2019

Base pair substitution mutagenschemicals that cause substitution of base pairs in the DNA.

ChemicalA substance or a mixture.

Cloning efficiencyThe percentage of cells plated at a low density that are able to grow into a colony that can be counted.

Concentrationsrefer to final concentrations of the test chemical in culture medium

CytotoxicityFor the assays covered in this test method, cytotoxicity is identified as a reduction in relative survival of the treated cells as compared to the negative control (see specific paragraph).

Forward mutationa gene mutation from the parental type to the mutant form which gives rise to an alteration or a loss of the enzymatic activity or the function of the encoded protein.

Frameshift mutagenschemicals which cause the addition or deletion of single or multiple base pairs in the DNA molecule.

Genotoxica general term encompassing all types of DNA or chromosomal damage, including DNA breaks, adducts, rearrangements, mutations, chromosome aberrations, and aneuploidy. Not all types of genotoxic effects result in mutations or stable chromosomal damage

HAT mediummedium containing Hypoxanthine, Aminopterin and Thymidine, used for cleansing of Hprt mutants.

Mitotic recombinationduring mitosis, recombination between homologous chromatids possibly resulting in the induction of DNA double strand breaks or in a loss of heterozygosity.

MPA mediummedium containing Xanthine, Adenine, Thymidine, Aminopterin and Mycophenolic acid, used for cleansing of Xprt mutants.

Mutagenicproduces a heritable change of DNA base-pair sequences(s) in genes or of the structure of chromosomes (chromosome aberrations).

Mutant frequency (MF)the number of mutant colonies observed divided by the number of cells plated in selective medium, corrected for cloning efficiency (or viability) at the time of selection.

Phenotypic expression timeThe time after treatment during which the genetic alteration is fixed within the genome and any preexisting gene products are depleted to the point that the phenotypic trait is altered.

Relative survival (RS)RS is used as the measure of treatment-related cytotoxicity. RS is cloning efficiency (CE) of cells plated immediately after treatment adjusted by any loss of cells during treatment as compared with cloning efficiency in negative controls (assigned a survival of 100 %).

S9 liver fractionssupernatant of liver homogenate after 9000g centrifugation, i.e. raw liver extract

S9 mixmix of the liver S9 fraction and cofactors necessary for metabolic enzyme activity.

Solvent controlGeneral term to define the control cultures receiving the solvent alone used to dissolve the test chemical.

Test chemicalAny substance or mixture tested using this test method.

Untreated controlcultures that receive no treatment (i.e. neither test chemical nor solvent) but are processed concurrently and in the same way as the cultures receiving the test chemical

UVCBChemical Substances of Unknown or Variable Composition, Complex Reaction Products and Biological Materials